FAERS Immunology Drug Safety: Adverse Event Reports from 2020–2025

535,632 structured adverse event reports for immunology and rheumatology drugs from the FDA's FAERS database, covering 2020–2025. The dataset, created by RubyIntelligence, includes serious events such as hospitalization, life-threatening outcomes, and death. Each record likely contains suspect drug(s), MedDRA-coded reactions, patient demographics, and outcome codes.

Use Cases

• Signal detection for specific immunology drugs based on reported adverse reactions.
• Temporal trend analysis of serious adverse events from 2020 to 2025.
• Demographic profiling of patients experiencing adverse events with rheumatology drugs.
• Outcome severity analysis based on reported hospitalization, life-threatening, and death codes.

Strengths

• 535,632 records provide a substantial sample for analysis.
• Data covers a specific five-year period from 2020 to 2025.
• Focus on serious adverse events (hospitalization, life-threatening, death) increases clinical relevance.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

FDA FAERS (FDA Adverse Event Reporting System)

Collection Method

Extracted and structured from the FAERS database by RubyIntelligence.

Time Range

2020–2025

Freshness

Last updated 2026-06-17 06:24:10; freshness should be verified.